The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global MicroRNA (miRNA) Market Research Report 2024

Global MicroRNA (miRNA) Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1886052

No of Pages : 84

Ask Your Query

Synopsis

The global MicroRNA (miRNA) market was valued at US$ 183.8 million in 2023 and is anticipated to reach US$ 382.1 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.

North American market for MicroRNA (miRNA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for MicroRNA (miRNA) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for MicroRNA (miRNA) in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of MicroRNA (miRNA) include Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc. and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for MicroRNA (miRNA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MicroRNA (miRNA).

Report Scope

The MicroRNA (miRNA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MicroRNA (miRNA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the MicroRNA (miRNA) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List)

  • Thermofisher Scientific (Life Technologies)
  • Agilent Technologies
  • Merck KGaA
  • QIAGEN (Exiqon)
  • NanoString Technologies, Inc.
  • Dharmacon (Horizon Discovery Group)
  • Synlogic
  • GeneCopoeia, Inc.
  • New England Biolabs
  • Quantabio
  • NanoString Technologies, Inc.
  • BioGenex
  • SeqMatic LLC

Segment by Type

  • Sample collection
  • miRNA cDNA Synthesis
  • Profiling & Purification
  • Detection
  • Functional Studies

Segment by Application

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MicroRNA (miRNA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MicroRNA (miRNA) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sample collection
1.2.3 miRNA cDNA Synthesis
1.2.4 Profiling & Purification
1.2.5 Detection
1.2.6 Functional Studies
1.3 Market by Application
1.3.1 Global MicroRNA (miRNA) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global MicroRNA (miRNA) Market Perspective (2019-2030)
2.2 MicroRNA (miRNA) Growth Trends by Region
2.2.1 Global MicroRNA (miRNA) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 MicroRNA (miRNA) Historic Market Size by Region (2019-2024)
2.2.3 MicroRNA (miRNA) Forecasted Market Size by Region (2025-2030)
2.3 MicroRNA (miRNA) Market Dynamics
2.3.1 MicroRNA (miRNA) Industry Trends
2.3.2 MicroRNA (miRNA) Market Drivers
2.3.3 MicroRNA (miRNA) Market Challenges
2.3.4 MicroRNA (miRNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MicroRNA (miRNA) Players by Revenue
3.1.1 Global Top MicroRNA (miRNA) Players by Revenue (2019-2024)
3.1.2 Global MicroRNA (miRNA) Revenue Market Share by Players (2019-2024)
3.2 Global MicroRNA (miRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MicroRNA (miRNA) Revenue
3.4 Global MicroRNA (miRNA) Market Concentration Ratio
3.4.1 Global MicroRNA (miRNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MicroRNA (miRNA) Revenue in 2023
3.5 MicroRNA (miRNA) Key Players Head office and Area Served
3.6 Key Players MicroRNA (miRNA) Product Solution and Service
3.7 Date of Enter into MicroRNA (miRNA) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MicroRNA (miRNA) Breakdown Data by Type
4.1 Global MicroRNA (miRNA) Historic Market Size by Type (2019-2024)
4.2 Global MicroRNA (miRNA) Forecasted Market Size by Type (2025-2030)
5 MicroRNA (miRNA) Breakdown Data by Application
5.1 Global MicroRNA (miRNA) Historic Market Size by Application (2019-2024)
5.2 Global MicroRNA (miRNA) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America MicroRNA (miRNA) Market Size (2019-2030)
6.2 North America MicroRNA (miRNA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America MicroRNA (miRNA) Market Size by Country (2019-2024)
6.4 North America MicroRNA (miRNA) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe MicroRNA (miRNA) Market Size (2019-2030)
7.2 Europe MicroRNA (miRNA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe MicroRNA (miRNA) Market Size by Country (2019-2024)
7.4 Europe MicroRNA (miRNA) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific MicroRNA (miRNA) Market Size (2019-2030)
8.2 Asia-Pacific MicroRNA (miRNA) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific MicroRNA (miRNA) Market Size by Region (2019-2024)
8.4 Asia-Pacific MicroRNA (miRNA) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America MicroRNA (miRNA) Market Size (2019-2030)
9.2 Latin America MicroRNA (miRNA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America MicroRNA (miRNA) Market Size by Country (2019-2024)
9.4 Latin America MicroRNA (miRNA) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MicroRNA (miRNA) Market Size (2019-2030)
10.2 Middle East & Africa MicroRNA (miRNA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa MicroRNA (miRNA) Market Size by Country (2019-2024)
10.4 Middle East & Africa MicroRNA (miRNA) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermofisher Scientific (Life Technologies)
11.1.1 Thermofisher Scientific (Life Technologies) Company Detail
11.1.2 Thermofisher Scientific (Life Technologies) Business Overview
11.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Introduction
11.1.4 Thermofisher Scientific (Life Technologies) Revenue in MicroRNA (miRNA) Business (2019-2024)
11.1.5 Thermofisher Scientific (Life Technologies) Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies MicroRNA (miRNA) Introduction
11.2.4 Agilent Technologies Revenue in MicroRNA (miRNA) Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA MicroRNA (miRNA) Introduction
11.3.4 Merck KGaA Revenue in MicroRNA (miRNA) Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 QIAGEN (Exiqon)
11.4.1 QIAGEN (Exiqon) Company Detail
11.4.2 QIAGEN (Exiqon) Business Overview
11.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Introduction
11.4.4 QIAGEN (Exiqon) Revenue in MicroRNA (miRNA) Business (2019-2024)
11.4.5 QIAGEN (Exiqon) Recent Development
11.5 NanoString Technologies, Inc.
11.5.1 NanoString Technologies, Inc. Company Detail
11.5.2 NanoString Technologies, Inc. Business Overview
11.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Introduction
11.5.4 NanoString Technologies, Inc. Revenue in MicroRNA (miRNA) Business (2019-2024)
11.5.5 NanoString Technologies, Inc. Recent Development
11.6 Dharmacon (Horizon Discovery Group)
11.6.1 Dharmacon (Horizon Discovery Group) Company Detail
11.6.2 Dharmacon (Horizon Discovery Group) Business Overview
11.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Introduction
11.6.4 Dharmacon (Horizon Discovery Group) Revenue in MicroRNA (miRNA) Business (2019-2024)
11.6.5 Dharmacon (Horizon Discovery Group) Recent Development
11.7 Synlogic
11.7.1 Synlogic Company Detail
11.7.2 Synlogic Business Overview
11.7.3 Synlogic MicroRNA (miRNA) Introduction
11.7.4 Synlogic Revenue in MicroRNA (miRNA) Business (2019-2024)
11.7.5 Synlogic Recent Development
11.8 GeneCopoeia, Inc.
11.8.1 GeneCopoeia, Inc. Company Detail
11.8.2 GeneCopoeia, Inc. Business Overview
11.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Introduction
11.8.4 GeneCopoeia, Inc. Revenue in MicroRNA (miRNA) Business (2019-2024)
11.8.5 GeneCopoeia, Inc. Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs MicroRNA (miRNA) Introduction
11.9.4 New England Biolabs Revenue in MicroRNA (miRNA) Business (2019-2024)
11.9.5 New England Biolabs Recent Development
11.10 Quantabio
11.10.1 Quantabio Company Detail
11.10.2 Quantabio Business Overview
11.10.3 Quantabio MicroRNA (miRNA) Introduction
11.10.4 Quantabio Revenue in MicroRNA (miRNA) Business (2019-2024)
11.10.5 Quantabio Recent Development
11.11 NanoString Technologies, Inc.
11.11.1 NanoString Technologies, Inc. Company Detail
11.11.2 NanoString Technologies, Inc. Business Overview
11.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Introduction
11.11.4 NanoString Technologies, Inc. Revenue in MicroRNA (miRNA) Business (2019-2024)
11.11.5 NanoString Technologies, Inc. Recent Development
11.12 BioGenex
11.12.1 BioGenex Company Detail
11.12.2 BioGenex Business Overview
11.12.3 BioGenex MicroRNA (miRNA) Introduction
11.12.4 BioGenex Revenue in MicroRNA (miRNA) Business (2019-2024)
11.12.5 BioGenex Recent Development
11.13 SeqMatic LLC
11.13.1 SeqMatic LLC Company Detail
11.13.2 SeqMatic LLC Business Overview
11.13.3 SeqMatic LLC MicroRNA (miRNA) Introduction
11.13.4 SeqMatic LLC Revenue in MicroRNA (miRNA) Business (2019-2024)
11.13.5 SeqMatic LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock